BOSTON—Due to the fact that pancreatic cancer often reoccurs, treatment
options are often limited to chemotherapy, but researchers at
Georgetown University in Washington, D.C., are utilizing Accuray’s
CyberKnife to see if radiosurgery is a viable treatment option in
select patients, according to a presentation delivered Sunday at the
50th annual meeting of the American Society for Therapeutic Radiology
and Oncology (ASTRO).

Bookmark to: